Date: Wednesday 5th December 2012
Venue: Old Theatre, Old Building, LSE
Speaker: Professor David Nutt (pictured)
Chair: Professor Craig Calhoun
LSE Health and Social Care is pleased to announce the 2012 Annual Lecture will be delivered by Professor David Nutt.
Professor Nutt's talk will reflected on these issues in the light of his ten years' experience on the government's Advisory Council on the Misuse of Drugs until 2010. He presented new analyses that compares the harms of drugs and alcohol using more sophisticated methodology and challenge many of the current misconceptions about drugs - their harms - and how to deal with them.
Please click here for the vodcast and podcast of this event.
David Nutt FMedSci is Professor of Neuropsychopharmacology at Imperial College London and a consultant psychiatrist in the Central and NorthWest London mental health trust where he conducts research into the be mechanisms of addiction and the effects of drugs on be function. He was chair of the ACMD until 2010 and is now the Chair of the Independent Scientific Committee on Drugs [ISCD] a charitable group that provides unbiased evidence about drugs actions and harms www.drugscience.org.uk.
He received his undergraduate training in medicine at Cambridge and Guy's Hospital, and continued training in neurology to MRCP. After completing his psychiatric training in Oxford, he continued there as a lecturer and then later as a Wellcome Senior Fellow in psychiatry. He then spent two years as Chief of the Section of Clinical Science in the National Institute of Alcohol Abuse and Alcoholism in NIH, Bethesda, USA. On returning to England in 1988 he set up the Psychopharmacology Unit in Bristol University, an interdisciplinary research grouping spanning the departments of Psychiatry and Pharmacology before moving to Imperial College London in December 2008 where he leads a similar group with a particular focus on brain imaging especially PET.
He is currently Chair of the Independent Scientific Committee on Drugs (ISCD), Past-President of the European College of Neuropsychopharmacology (ECNP), Vice-President of the European Brain Council, President of the British Neuroscience Association and a member of the International Centre for Science in Drug Policy. In addition, he has edited the Journal of Psychopharmacology for over a decade and acts as a psychiatry advisor to the British National Formulary. He has published over 400 original research papers, a similar number of reviews and books chapters, eight government reports on drugs and 28 books.
Previously he has been member and Chair of the Advisory Committee on the Misuse of Drugs (ACMD – 1998-2009), President of the British Association of Psychopharmacology (BAP), member of the HEFCE/NHS Senior Lecturer Selection Panel and member of the MRC Neuroscience Board. Other previous national contributions include membership of the Independent Inquiry into the Misuse of Drugs Act (2000 Runciman report), and membership of the Committee on Safety of Medicines (2000 – 2005) and member of the Ministry of Defence Science Advisory Board (2005-2007). He was the clinical scientific lead on the 2004/5 UK Government Foresight initiative “Brain science, addiction and drugs” that provided a 25-year vision for this area of science and public policy and in 2006 he was Director of Bristol Neuroscience.
He broadcasts widely to the general public both on radio and television including a recent BBC Horizon episode on drug harms and their classification. He also lectures widely to the public as well as to the scientific and medical communities; for instance, has presented four times at the Cheltenham Science Festival and several times for Café Scientifiques. In 2010 he was listed as one of the 100 most important figures in British Science by The Times Eureka science magazine.